Shi‐Shan Mao
Genomics Research Center, Academia Sinica(TW)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Peptidase Inhibition and Analysis, Hepatitis C virus research, Protease and Inhibitor Mechanisms, HIV/AIDS drug development and treatment
Most-Cited Works
- → Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection(2021)188 cited
- → Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor(2010)176 cited
- → Molecular Modeling Based Approach to Potent P2−P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease(2008)134 cited
- → Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B(1999)132 cited
- → Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position(1997)57 cited
- → Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P 1 ′ group(2004)56 cited
- → Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics(2003)42 cited
- → Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice(2005)37 cited
- → Inhibition of Thrombin by Peptides Containing Lysyl-α-Keto Carbonyl Derivatives(1995)32 cited
- → A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3–4A protease at low enzyme concentrations(2007)30 cited